High HVEM and low BTLA mRNA levels in tumor cells from patients with follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) were associated with shorter time-to-treatment, overall survival, and increased risk of transformation from FL to DLBCL [80, 81]. Here, BTLA is linked to diffuse large B-cell lymphoma.